Paper6470977
Role of the gut flora in the reduction of sulfinpyrazone in humans.
Strong HA and 4 others. J Pharmacol Exp Ther, 1984. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. Role of the gut flora in the reduction of sulfinpyrazone in humans. Papers, record 6470977. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6470977
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Digestive System | Major topic |
| Sulfinpyrazone | Major topic |
| Administration, Oral | |
| Adult | |
| Biological Availability | |
| Enterobacteriaceae | |
| Feces | |
| Female | |
| Half-Life | |
| Humans | |
| Ileostomy | |
| Kinetics | |
| Male | |
| Metoclopramide | |
| Middle Aged | |
| Sulfides |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42148403 | Scientific Opinion on Flavouring Group Evaluation 8, Revision 3 (FGE.08Rev3): Aliphatic and alicyclic mono-, di-, tri-, and polysulphides with or without additional oxygenated functional groups from chemical groups 20 and 30. | EFSA J | 2011 | https://conductscience.org/library/papers/42148403 | PubMed |
| 42079543 | Flavouring Group Evaluation 08 Rev2 (FGE.08 Rev2): Aliphatic and alicyclic mono-, di-, tri-, and polysulphides with or without additional oxygenated functional groups from chemical groups 20 and 30. | EFSA J | 2010 | https://conductscience.org/library/papers/42079543 | PubMed |
| 42016132 | Scientific Opinion on Flavouring Group Evaluation 08, Revision 5 (FGE.08Rev5): Aliphatic and alicyclic mono-, di-, tri-, and polysulphides with or without additional oxygenated functional groups from chemical groups 20 and 30. | EFSA J | 2012 | https://conductscience.org/library/papers/42016132 | PubMed |
| 42005759 | Flavouring Group Evaluation 8, Revision 1 (FGE.08Rev1): Aliphatic and alicyclic mono-, di-, tri-, and polysulphides with or without additional oxygenated functional groups from chemical groups 20 and 30. | EFSA J | 2010 | https://conductscience.org/library/papers/42005759 | PubMed |
| 41017122 | Pharmacomicrobiomics. | Clin Pharmacol Ther | 2025 | https://conductscience.org/library/papers/41017122 | PubMed |
| 24271526 | Pharmacokinetics and Reversible Biotransformation of Sulfinpyrazone and Its Metabolites in Rabbits. II. Multiple-Dose Study. | Pharm Res | 1986 | https://conductscience.org/library/papers/24271526 | PubMed |
| 24271525 | Pharmacokinetics and reversible biotransformation of sulfinpyrazone and its metabolites in rabbits. I. Single-dose study. | Pharm Res | 1986 | https://conductscience.org/library/papers/24271525 | PubMed |
| 23343017 | Intestinal transport as a potential determinant of drug bioavailability. | Curr Clin Pharmacol | 2013 | https://conductscience.org/library/papers/23343017 | PubMed |
| 3816927 | Renal clearance of sulphinpyrazone in man. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3816927 | PubMed |
| 3780113 | Effects of ischaemic heart disease, Crohn's disease and antimicrobial therapy on the pharmacokinetics of sulphinpyrazone. | Clin Pharmacokinet | 1986 | https://conductscience.org/library/papers/3780113 | PubMed |
| 2686883 | Clinical pharmacokinetic considerations in the elderly. An update. | Clin Pharmacokinet | 1989 | https://conductscience.org/library/papers/2686883 | PubMed |
| 2686738 | Prodrugs. | Br J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2686738 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6470977
GET https://conductscience.org/api/papers/v1/6470977/authors